Legal & General Group
SVRA icon

Legal & General Group’s Savara SVRA Stock Holding History

Legal & General Group’s Portfolio SVRA Stock Details SVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$351K Buy
56,951
+23,338
+69% +$125K ﹤0.01% 2472
2026
Q1 		$184K Buy
33,613
+18,760
+126% +$104K ﹤0.01% 2550
2025
Q4 		$89.6K Buy
14,853
+2,751
+23% +$13.5K ﹤0.01% 2646
2025
Q3 		$43.2K Sell
12,102
-42,595
-78% -$126K ﹤0.01% 2766
2025
Q2 		$125K Sell
54,697
-42,119
-44% -$115K ﹤0.01% 2627
2025
Q1 		$268K Buy
96,816
+1,239
+1% +$3.42K ﹤0.01% 2567
2024
Q4 		$293K Hold
95,577
– – ﹤0.01% 2609
2024
Q3 		$405K Buy
95,577
+26,165
+38% +$116K ﹤0.01% 2529
2024
Q2 		$280K Buy
69,412
+5,398
+8% +$24K ﹤0.01% 2619
2024
Q1 		$319K Buy
64,014
+56,505
+752% +$273K ﹤0.01% 2593
2023
Q4 		$35.3K Hold
7,509
– – ﹤0.01% 2864
2023
Q3 		$28.4K Buy
7,509
+152
+2% +$542 ﹤0.01% 2934
2023
Q2 		$23.5K Buy
+7,357
New +$17.3K ﹤0.01% 3044
2021
Q2 		– Sell
-3,590
Closed -$7K – 3637
2021
Q1 		$7K Hold
3,590
– – ﹤0.01% 3451
2020
Q4 		$4K Hold
3,590
– – ﹤0.01% 3446
2020
Q3 		$4K Sell
3,590
-2,273
-39% -$3.89K ﹤0.01% 3396
2020
Q2 		$15K Buy
5,863
+60
+1% +$146 ﹤0.01% 3191
2020
Q1 		$12K Hold
5,803
– – ﹤0.01% 3117
2019
Q4 		$26K Buy
5,803
+1,363
+31% +$1.64K ﹤0.01% 3110
2019
Q3 		$12K Hold
4,440
– – ﹤0.01% 3243
2019
Q2 		$11K Hold
4,440
– – ﹤0.01% 3346
2019
Q1 		$33K Hold
4,440
– – ﹤0.01% 2891
2018
Q4 		$34K Hold
4,440
– – ﹤0.01% 2853
2018
Q3 		$50K Buy
4,440
+714
+19% +$8.21K ﹤0.01% 2770
2018
Q2 		$42K Buy
+3,726
New +$37.4K ﹤0.01% 2834

Other funds holding SVRA

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Legal & General Group's SVRA Position: Q2 2026 in Review

Legal & General Group increased its Savara (SVRA) stake by 69% in Q2 2026, buying an estimated $125K and bringing the position to 56,951 shares worth $351K. The position accounts for ﹤0.01% of the portfolio, ranked #2472.

Legal & General Group first reported a position in SVRA in Q2 2018 and has held it in 25 quarters since. The position peaked at $405K in Q3 2024. 180 funds tracked by Wall St. Rank hold SVRA as of Q2 2026.

  • Legal & General Group held 56,951 shares of Savara worth $351K as of Q2 2026.
  • Legal & General Group bought 23,338 Savara shares in Q2 2026, an estimated $125K.
  • Savara made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #2472 holding.
  • Legal & General Group first reported a position in Savara in Q2 2018 and has held it in 25 quarters since.
  • Legal & General Group's Savara position peaked at $405K in Q3 2024.
  • 180 funds tracked by Wall St. Rank held Savara as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.